{
    "clinical_study": {
        "@rank": "153213", 
        "acronym": "11SEHS", 
        "arm_group": {
            "arm_group_label": "Spanish Black Radish", 
            "arm_group_type": "Experimental", 
            "description": "Spanish Black Radish product"
        }, 
        "brief_summary": {
            "textblock": "This study will investigate the effect of Spanish Black Radish on phase I and phase II\n      enzyme activity in healthy adult males.  The primary objective is to determine the effect on\n      phase I and phase II enzyme activity by measuring plasma and urine acetaminophen metabolite\n      concentrations prior to and after a 28 day supplementation period with Spanish black radish\n      product."
        }, 
        "brief_title": "An Open Label Pilot Study to Evaluate the Efficacy of Spanish Black Radish on the Induction of Phase I and Phase II Enzymes", 
        "completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male age 25 - 35 years\n\n          -  BMI 18 - 25 kg/m2\n\n          -  Healthy as determined by laboratory results, medical history\n\n          -  Agrees to avoid the consumption of cruciferous vegetables for 14 days prior to\n             baseline and during the study treatment period\n\n          -  Has given voluntary, written, informed consent to participate in the study\n\n        Exclusion Criteria:\n\n          -  Chronic diseases or any medical conditions\n\n          -  Gall bladder disorders and /or bowel obstruction\n\n          -  Use of prescribed or over the counter medications for the treatment of any acute or\n             chronic conditions\n\n          -  Use of muscle building steroids or body building aids\n\n          -  Use of products containing ingredients derived from the Cruciferae (Brassicaracea)\n             plant family within 14 days prior to randomization\n\n          -  Use of natural health products other than vitamins or minerals within 14 days prior\n             to randomization\n\n          -  Any clinically significant abnormal laboratory value.  Meaning a disease process, an\n             exacerbation or worsening of an existing condition, requires further or more frequent\n             monitoring or requires further action(s) to be taken.  Clinical significance can only\n             be determined by the Qualified Investigator.\n\n          -  Participation in a clinical research trial within 30 days prior to randomization\n\n          -  Allergy or sensitivity to test product ingredients, Cruciferae/Brassicaracea plant\n             family (includes mustard, cabbage, radish), acetaminophen or foods and beverages\n             provided during the study\n\n          -  Individuals who are cognitively impaired and/or who are unable to give informed\n             consent\n\n          -  Any other condition which in the Investigator's opinion may adversely affect the\n             subject's ability to complete the study or its measures or which may pose significant\n             risk to the subject\n\n          -  Cannot take acetaminophen within 48 hrs of the baseline appointment or final 4-wk\n             appointment."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02137590", 
            "org_study_id": "11SEHS"
        }, 
        "intervention": {
            "arm_group_label": "Spanish Black Radish", 
            "intervention_name": "Spanish Black Radish product", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Spanish Black Radish", 
            "Phase I detoxification enzymes", 
            "Phase II detoxification enzymes", 
            "Acetaminophen"
        ], 
        "lastchanged_date": "May 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N6A 5R8"
                }, 
                "name": "KGK Synergize Inc."
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open Label Pilot Study to Evaluate the Efficacy of Spanish Black Radish on the Induction of Phase I and Phase II Enzymes in Healthy Male Subjects", 
        "other_outcome": [
            {
                "description": "Assessment of CBC, electrolytes (Na, K, Cl), creatinine, AST, ALT, GGT, and bilirubin", 
                "measure": "Blood Safety Parameters", 
                "safety_issue": "Yes", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Assessment of Blood Pressure and Heart Rate", 
                "measure": "Vital Signs", 
                "safety_issue": "Yes", 
                "time_frame": "4 weeks"
            }, 
            {
                "description": "Assessment of any adverse events occurring during the study", 
                "measure": "Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "4 weeks"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "KGK Synergize Inc.", 
                "last_name": "Dale Wilson, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "KGK Synergize Inc.", 
                "last_name": "Malkanthi Evans, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Health Canada"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The effect on phase I and phase II enzyme activity determined by measuring plasma and urine acetaminophen metabolite concentrations Subjects will ingest 1000 mg of acetaminophen.  Blood will be collected at 0, 2, 4, 6 and 8 hours after acetaminophen dosage for the analysis of plasma acetaminophen metabolites.  These measurements will be performed prior to and after 4 weeks of treatment with Spanish Black Radish product.", 
            "measure": "Effect on Phase I and II enzymes", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02137590"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Assessment of serum total testosterone, free testosterone and estradiol 17 beta", 
            "measure": "Assessment of Hormone Levels", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "KGK Synergize Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Standard Process Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "KGK Synergize Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}